Bespoke Extracts (BSPK) 10-Q 1 May 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Feb. 28, 2019	Apr. 30, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	Bespoke Extracts, Inc.
Entity Central Index Key	0001409197
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Document Type	10-Q
Trading Symbol	BSPK
Document Period End Date	Feb. 28, 2019
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		76,670,574

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Feb. 28, 2019	Aug. 31, 2018
Current assets
Cash	$ 110,103	$ 79,784
Accounts receivable	6,013	2,004
Prepaid expense	27,564	30,976
Inventory	54,184	61,857
Total current assets	197,864	174,621
Domain names, net of amortization of $6,691 and $5,019	43,494	45,166
Total assets	241,358	219,787
Current liabilities
Accounts payable and accrued liabilities	178,916	105,424
Convertible notes - related parties, net of unamortized discounts $107,985 and $199,300, respectively	732,015	460,700
Note payable - related party	50	50
Total current liabilities	910,981	566,174
Non-current liabilities
Related party convertible note payable, net of unamortized discounts $0 and $98,847		81,153
Total non-current liabilities		81,153
Total liabilities	910,981	647,327
Stockholders' Deficit
Series A Convertible Preferred Stock, $0.001 par value, 50,000,000 authorized shares; no shares issued and outstanding as of February 28, 2019 and August 31, 2018, respectively
Common stock, $0.001 par value: 800,000,000 authorized;56,869,379 and 42,902,712 shares issued and outstanding as of February 28, 2019 and August 31, 2018, respectively	56,870	42,903
Additional paid-in capital	12,568,886	16,246,201
Common stock payable	76,000
Accumulated deficit	(13,371,379)	(16,716,644)
Total stockholders’ deficit	(669,623)	(427,540)
Total liabilities and stockholders' deficit	$ 241,358	$ 219,787

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Feb. 28, 2019	Aug. 31, 2018
Statement of Financial Position [Abstract]
Net of amortization cost	$ 6,691	$ 5,019
Convertible debt, unamortized discounts	107,985	199,300
Unamortized discount net	$ 0	$ 98,847
Series A convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series A convertible preferred stock, shares authorized	50,000,000	50,000,000
Series A convertible preferred stock, shares issued
Series A convertible preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	800,000,000	800,000,000
Common stock, shares issued	56,869,379	42,902,712
Common stock, shares outstanding	56,869,379	42,902,712

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2019	Feb. 28, 2018	Feb. 28, 2019	Feb. 28, 2018
Income Statement [Abstract]
Sales	$ 12,509		$ 53,940
Total Sales	12,509		53,940
Cost of products sold	4,280		15,888
Gross Profit	8,229		38,052
Operating expenses:
Selling, general and administrative expenses	239,560	1,604,256	(3,838,781)	2,539,001
Payroll expense		1,743		21,114
Professional fees	68,488	27,677	106,483	51,640
Consulting	59,000	22,415	114,500	77,000
Promotion		20,365		20,365
Amortization expense	837	796	1,673	1,632
Total operating expenses	367,885	1,677,252	(3,616,125)	2,710,752
Loss from operations	(359,656)	(1,677,252)	3,654,177	(2,710,752)
Other expense
Make good common share expense			(76,000)
Interest expense	(148,879)	(83,124)	(232,912)	(186,670)
Total other expense	(148,879)	(83,124)	(308,912)	(186,670)
Loss before income tax	(508,535)	(1,760,376)	3,345,265	(2,897,422)
Provision for income tax
Net Income / (Loss)	$ (508,535)	$ (1,760,376)	$ 3,345,265	$ (2,897,422)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic and Diluted	52,132,342	32,540,490	48,551,147	30,550,613
NET INCOME / (LOSS) PER COMMON SHARE OUTSTANDING
Basic and Diluted	$ (0.01)	$ (0.05)	$ 0.07	$ (0.09)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Feb. 28, 2019	Feb. 28, 2018
Cash flows from operating activities
Net Income / (Loss)	$ 3,345,265	$ (2,897,422)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Amortization expense	1,673	1,632
Amortization of debt discounts	190,162	200,521
Gain on forfeited unvested employee stock award (net of cash paid of $1,600)	(2,440,768)
Option and warrant (gain)/expense	(1,629,580)	579,419
Common stock issued for services	120,000	1,855,043
Make good common share expense	76,000
Changes in operating assets and liabilities
Accounts receivable	(4,009)
Inventory	7,673	(69,522)
Prepaid expense	3,412	19,952
Accounts payable and accrued liabilities	73,492	(1,794)
Deposit for future assets sales from related party		82,750
Net Cash used in operating activities	(256,681)	(229,380)
Cash flow from financing activities
Borrowings on related party convertible debt		220,000
Proceeds from exercise of warrants	2,000
Sale of common stock	285,000
Sale of common stock and warrants		60,300
Net cash provided by financing activities	287,000	280,300
Net increase in cash and cash equivalents	30,319	50,920
Cash and cash equivalents at beginning of period	79,784	87,172
Cash and cash equivalents at end of period	110,103	138,092
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Discount due beneficial conversion feature		123,000
Stock issued for conversion of debt - related party		35,200
Stock issued with related party debt		51,503
Warrants issued with related party debt		$ 16,996

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical)	6 Months Ended
	Feb. 28, 2019USD ($)
Statement of Cash Flows [Abstract]
Gain on forfeited unvested employee stock award	$ 1,600

Consolidated Statement of Owner

Consolidated Statement of Owners Equity Deficit (Unaudited) - USD ($)	Preferred Shares Outstanding	Common Shares Outstanding	APIC	Common Stock Payable	Accumulated Deficit	Total
Balance at Aug. 31, 2017		$ 26,823	$ 8,808,161		$ (9,107,086)	$ (272,102)
Balance, shares at Aug. 31, 2017		26,822,712
Beneficial conversion on debt			123,000			123,000
Sale of common stock		$ 900	59,400			60,300
Sale of common stock, shares		900,000
Common stock issued for conversion of debt		$ 2,850	19,950			22,800
Common stock issued for conversion of debt, shares		2,850,000
Common stock issued with debt		$ 900	50,603			51,503
Common stock issued with debt, shares		900,000
Option expense			21,585			21,585
Stock based compensation			914,044			914,044
Warrants issued with debt			16,996			16,996
Net loss/income					(1,137,046)	(1,137,046)
Balance at Nov. 30, 2017		$ 31,473	10,013,739		(10,244,132)	(198,920)
Balance, shares at Nov. 30, 2017		31,472,712
Balance at Aug. 31, 2017		$ 26,823	8,808,161		(9,107,086)	(272,102)
Balance, shares at Aug. 31, 2017		26,822,712
Net loss/income						(2,897,422)
Balance at Feb. 28, 2018		$ 33,023	11,523,422		(12,004,508)	(448,063)
Balance, shares at Feb. 28, 2018		33,022,712
Balance at Nov. 30, 2017		$ 31,473	10,013,739		(10,244,132)	(198,920)
Balance, shares at Nov. 30, 2017		31,472,712
Common stock issued with debt		$ 1,550	10,850			12,400
Common stock issued with debt, shares		1,550,000
Option expense			579,419			579,419
Stock based compensation			919,414			919,414
Net loss/income					(1,760,376)	(1,760,376)
Balance at Feb. 28, 2018		$ 33,023	11,523,422		(12,004,508)	(448,063)
Balance, shares at Feb. 28, 2018		33,022,712
Balance at Aug. 31, 2018		$ 42,903	16,246,201		(16,716,644)	(427,540)
Balance, shares at Aug. 31, 2018		42,902,712
Sale of common stock		$ 2,000	118,000			120,000
Sale of common stock, shares		2,000,000
Forfeiture of stock issued through warrant exercise, net of cash paid		$ (16,000)	(2,424,768)			(2,440,768)
Forfeiture of stock issued through warrant exercise, net of cash paid, shares		(16,000,000)
Common stock issued for the exercise of warrants		$ 20,000	(18,000)			2,000
Common stock issued for the exercise of warrants, shares		20,000,000
Common stock issued for services		$ 1,000	119,000			120,000
Common stock issued for services, shares		1,000,000
Option and warrant gain/expense			(1,801,526)			(1,801,526)
Make good common share expense				76,000		76,000
Net loss/income					3,853,800	3,853,800
Balance at Nov. 30, 2018		$ 49,903	12,238,907	76,000	(12,862,844)	(498,034)
Balance, shares at Nov. 30, 2018		49,902,712
Balance at Aug. 31, 2018		$ 42,903	16,246,201		(16,716,644)	(427,540)
Balance, shares at Aug. 31, 2018		42,902,712
Net loss/income						3,345,265
Balance at Feb. 28, 2019		$ 56,869,379	12,568,886	76,000	(13,371,379)	(669,623)
Balance, shares at Feb. 28, 2019		56,870
Balance at Nov. 30, 2018		$ 49,903	12,238,907	76,000	(12,862,844)	(498,034)
Balance, shares at Nov. 30, 2018		49,902,712
Sale of common stock		$ 6,967	158,033			165,000
Sale of common stock, shares		6,966,667
Option and warrant gain/expense			171,946			171,946
Net loss/income					(508,535)	(508,535)
Balance at Feb. 28, 2019		$ 56,869,379	$ 12,568,886	$ 76,000	$ (13,371,379)	$ (669,623)
Balance, shares at Feb. 28, 2019		56,870

Nature of Operations, Significa

Nature of Operations, Significant Accounting Policies and Going Concern	6 Months Ended
	Feb. 28, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN	NOTE 1. — NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Bespoke Extracts, Inc, a Nevada corporation (the “Company”), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company’s annual report on Form 10-K for the fiscal year ended August 31, 2018 filed with the Securities and Exchange Commission (the “SEC”) on December 14, 2018. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of February 28, 2019, and the results of operations and cash flows for the three and six months ended February 28, 2019 and 2018. The results of operations for the six months ended February 28, 2019 are not necessarily indicative of the results that may be expected for the entire fiscal year. Certain prior period amounts have been reclassified to conform to current period presentation. Going Concern The accompanying unaudited consolidated financial statements have been prepared assuming a continuation of the Company as a going concern. The Company has a working capital deficit as of February 28, 2019 and negative cash flows from operations for the six months ended February 28, 2019. These conditions raise substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty. Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and market being determined as the lower of replacement cost or net realizable value. The Company records inventory write-downs for estimated obsolescence of unmarketable inventory based upon assumptions about future demand and market conditions. As of February 28, 2019 and August 31, 2018, inventory amounted to $54,184 and $61,857, respectively, which consisted of finished goods. Revenue Recognition The Company recognizes revenue from product sales to customers, distributors and resellers when products that do not require further services or installation by the Company are shipped, when there are no uncertainties surrounding customer acceptance and when collectability is reasonably assured. Cash received by the Company prior to shipment is recorded as deferred revenue. Sales are made to customers under terms allowing certain limited rights of return and other limited product and performance warranties for which provision has been made in the accompanying unaudited consolidated financial statements. Amounts billed to customers in sales transactions related to shipping and handling, represent revenues earned for the goods provided and are included in net sales. Costs of shipping and handling are included in cost of products sold. The Company accounts for revenue in accordance with Topic 606 which was adopted at the beginning of fiscal year 2018 using the modified retrospective method. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the effect was immaterial. Net Income / Loss per Share Basic income / loss per share amounts are computed based on net income / loss divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. Outstanding options, warrants and convertible debt were excluded from the calculation of diluted income / loss per share during 2018 and 2017 because their inclusion would have been anti-dilutive.

Asset Purchase Agreement

Asset Purchase Agreement	6 Months Ended
	Feb. 28, 2019
Offsetting [Abstract]
ASSET PURCHASE AGREEMENT	2. ASSET PURCHASE AGREEMENT On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain the domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company’s common stock valued at $30,000. For the three and six months ended February 28, 2019 and 2018 amortization expense amounted to $837, $796, $1,673 and $1,632, respectively. The domain names are being amortized over a 15 year period.

Note Payable - Related Party

Note Payable - Related Party	6 Months Ended
	Feb. 28, 2019
Debt Disclosure [Abstract]
NOTE PAYABLE - RELATED PARTY	3. NOTE PAYABLE – RELATED PARTY On April 27, 2016, the Company issued its CEO a 7% unsecured promissory note in the amount of $2,500 which matured six months from the date of issuance. On July 5, 2016, the Company issued its CEO a 7% unsecured note in the amount of $3,000 which matured six months from date of issuance. On November 17, 2016, the Company repaid the principal amount of the notes, or $5,500. The changes in notes payable to these related parties consisted of the following during the three months ended February 28, 2019 and the year ended August 31, 2018. February 28, August 31, Notes payable – related party at beginning of period $ 50 $ 50 Payments on notes payable – related party - - Borrowings on notes payable – related party - - Note payable – related party at end of period $ 50 $ 50 On February 14, 2017, the Company issued to Lyle Hauser, the Company’s largest shareholder at the time, a 7% unsecured promissory note in the amount of $30,000 which matured six months from the date of issuance. On May 31, 2018 the Company repaid the promissory note in the amount of $30,000 and accrued interest of $2,811. On May 17, 2016, the Company issued to The Vantage Group Ltd. (“Vantage”), a significant shareholder at that time, a 7% unsecured promissory note in the amount of $10,000 which had an original maturity of six months from the date of issuance. On August 15, 2016, the Company issued to Vantage a 7% unsecured promissory note in the amount of $16,000 which had an original maturity of six months from the date of issuance. On October 27, 2016, the Company issued the same shareholder a 7% unsecured promissory note in the amount of $10,000 which had an original maturity date of six months from the date of issuance. On November 14, 2016, the Company issued the same shareholder a 7% unsecured promissory note in the amount of $80,000 which had an original maturity date of six months from the date of issuance. On March 31, 2017, the Company issued the same shareholder a 7% unsecured promissory note in the amount of $7,000 which had an original maturity date of six months from the date of issuance. On April 17, 2017 the preceding notes issued to Vantage were amended to be convertible into common stock and to mature on April 18, 2018. The convertible notes had a fixed conversion price of $0.008. The amendments to the notes created a beneficial conversion feature of $123,000 and amortization of the discount of $123,000 during the year ended August 31, 2018. The Company issued a total of 10,050,000 shares of common stock to convert $80,000 principal and $400 of accrued interest into common stock and the remaining $43,000 was exchanged with an additional $2,000 of accrued interest to purchase assets of the Company. The changes in notes payable to these related parties consisted of the following during the six months ended February 28, 2019 and the year ended August 31, 2018. February 28, August 31, 2018 Notes payable – related party at beginning of period $ - $ 153,000 Payments on notes payable – related party - (30,000 ) Conversion - (80,000 ) Exchange for purchase of Company assets - (43,000 ) Note payables – related party at end of period $ - $ -

Convertible Debenture - Related

Convertible Debenture - Related Party	6 Months Ended
	Feb. 28, 2019
Convertible Debenture Related Party [Abstract]
CONVERTIBLE DEBENTURE - RELATED PARTY	4. CONVERTIBLE DEBENTURE – RELATED PARTY On April 11, 2017, the Company executed a $540,000 related party convertible debenture with an original issue discount of $180,000. The note had a 0% interest rate and a term of two years, and provided that, if it were not paid in full on the due date, the note would have a 0% interest rate until paid in full. In connection with the note, the Company issued the lender an aggregate of 2,700,000 shares of common stock and 900,000 warrants. The relative fair value of the stock ($157,509) and warrants ($44,981) aggregating $202,490 was recognized as a discount to the note. Amortization of $99,776 and $143,132 was recognized during the three and six months ended February 28, 2019. The conversion price of the outstanding balance is the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the note the lender was entitled to receive greater of 5% every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principal. As of February 28, 2019 and August 31, 2018 the Company has accrued $48,265 and $34,015, respectively. This note has been exchanged for shares of common stock of the Company. See Note 7. February 28, August 31, Related Party Convertible debenture $ 540,000 $ 540,000 Unamortized discount (41,232 ) (184,364 ) Related Party Convertible debenture, net of unamortized discount $ 498,768 $ 355,636 On August 28, 2017, the Company executed, with a related party, an $180,000 convertible debenture with an original issue discount of $60,000. The note had a 0% interest rate and a term of two years. In connection with the note, the Company issued the lender an aggregate of 900,000 shares of common stock and 300,000 warrants to purchase common stock. The relative fair value of the stock and warrants aggregating $68,499 was recognized as a discount to the note. Amortization of $16,032 and $32,094 was recognized during the three and six months ended February 28, 2019. The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the debenture the lender was entitled to receive the greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of the maturity date or repayment of the principal. As of February 28, 2019 and August 31, 2018 the Company has accrued $39,250 and $25,000, respectively. This note has been exchanged for shares of common stock of the Company. See Note 7. February 28, August 31, Related Party Convertible debenture $ 180,000 $ 180,000 Unamortized discount (66,753 ) (98,847 ) Related Party Convertible debenture, net of unamortized discount $ 113,247 $ 81,153 On December 13, 2017, the Company executed a $120,000 convertible debenture with an original issue discount of $20,000. The debenture had a 0% interest rate and a term of one year. In connection with the note, the Company issued the lender an aggregate of 200,000 shares of common stock and 100,000 warrants to purchase common stock. The relative fair value of the stock and warrants aggregating $32,930 was recognized as a discount to the note. Amortization of $8,320 and $14,936 was recognized during the three and six months ended February 28, 2019. The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the debenture the lender was entitled to receive the greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principal. As of February 28, 2019 and August 31, 2018 the Company has accrued $34,250 and $20,000, respectively. This note has been exchanged for shares of common stock of the Company. See Note 7. February 28, August 31, Related Party Convertible debenture $ 120,000 $ 120,000 Unamortized discount - (14,936 ) Related Party Convertible debenture, net of unamortized discount $ 120,000 $ 105,064

Equity

Equity	6 Months Ended
	Feb. 28, 2019
Equity [Abstract]
EQUITY	5. EQUITY Common Stock The Company has authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of Series A Convertible Preferred stock with a par value of $0.001. Between September 1, 2018 and February 28, 2019 the Company sold a total of 8,966,667 shares of common stock for proceeds of $285,000. On October 13, 2018 the Company issued 1,000,000 shares of common stock for a sponsorship donation valued at $120,000. Effective October 30, 2018, Marc Yahr resigned from all positions with the Company including as President and Chief Executive Officer of the Company, except as a member of the board of directors. On November 25, 2018 Mr. Yahr resigned as a member of the Company’s board of directors. On November 6, 2018, 16,000,000 shares of common stock were returned to the Company by Mr. Yahr for which the Company paid $1,600 to Marc Yahr. This forfeiture was in accordance with the terms of this May 22, 2017 employee share based award and the forfeiture resulted in a gain of $2,440,768 (net of the $1,600 cash paid) representing a reversal of the previously recognized expense for the unvested portion of this freighted award. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel’s annual salary is $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant for $2,000 and was issued the 20,000,000 shares on October 31, 2018. The shares received upon the exercise of the warrants are subject to forfeiture over a service period of four years. Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of February 28, 2019 the Company was obligated to issue 500,000 shares of common stock valued at $76,000. Warrants On May 22, 2017, the Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Mr. Yahr received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. The warrants were exercised in full on May 31, 2017; however, the 20,000,000 shares of the Company’s common stock were not issued to Mr. Yahr until June 10, 2017. The shares received upon the exercise of the warrants were subject to forfeiture over a service period of three years. The fair value of the award was determined to be $10,998,105 which will be recognized as compensation expense over the three year service period. Effective October 30, 2018, Marc Yahr resigned from all positions with the Company including as President and Chief Executive Officer of the Company (except as director, which he resigned as on November 25, 2018). Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company. As of February 28, 2019, $0 remains to be expensed over the remaining vesting period. On January 22, 2018, the Company entered into a sales representation agreement for a term of six months. Pursuant to the agreement the Company agreed to issue the nonemployee sales representative warrants to purchase 10,000 shares of common stock per month (an aggregate of 60,000 warrants) with an exercise price of $0.50, with a term of three years. The warrants shall be exercisable at any time on or after the six (6) month anniversary of each issuance date, at his election, in whole or in part, by means of a cashless exercise. During the three and six months ended February 28, 2019 the Company recognized a gain of ($197) and $(32,061), respectively due to a remeasurement of this nonemployee award. On February 22, 2018, the Company entered into a consulting agreement for a term of one year. Pursuant to the agreement the Company agreed to issue the nonemployee consultant warrants to purchase 10,000 shares of common stock per month (an aggregate of 120,000 warrants) with an exercise price of $0.40, exercisable for cash only for a period of three years commencing six months form the issuance date. During the three and six months ended February 28, 2019 the Company recognized a gain / (expense) of $321 and $(57,382), respectively due to a remeasurement of this nonemployee award. On March 2, 2018 the Company entered into a management agreement with Global Corporate Management, LLC. Pursuant to this agreement, the Company agreed to pay $4,000 and to issue 150,000 common stock purchase warrants per month (an aggregate of 3,600,000 warrants) with an exercise price of $0.50, exercisable commencing six months after issuance for a period of 5 years. During the three and six months ended February 28, 2019 the Company recognized a (gain) / expense of $(8,363) and $(1,273,049), respectively due to a remeasurement of this nonemployee award. On April 16, 2018 The Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000 warrants each month to purchase common stock with an exercise price of $0.60. However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exercised on a cashless basis. Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month (an aggregate of 720,000 warrants) to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. During the three and months ended February 28, 2019 the Company recognized a (gain) / expense of $8,225 and $(107,618), respectively due to a remeasurement of this nonemployee award. On October 30, 2018, the Company entered into an employment agreement with Ms. Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel’s annual salary is $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $162,384 and $216,512 was recognized during the three and six months ended February 28, 2019, respectively. Unamortized expense at February 28, 2019 is $2,381,627. The shares received upon the exercise of the warrants are subject to forfeiture over a service period of four years. The shares will be required to be returned to the Company as follows and the Company accounts for forfeitures when they occur: Ms. Noel shall return 80% of the common stock to the Company if she is not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of her employment agreement as of October 2019 (the first anniversary of the employment agreement); Ms. Noel shall return 60% of the common stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the second anniversary of the employment agreement (October, 2020); Ms. Noel shall return 40% of the common stock to the Company if she is not serving as Chief Executive Officer of the Company pursuant to the terms and conditions of the employment agreement as of the third anniversary of the employment agreement (October 2021); Ms. Noel shall return 20% of the Common Stock to the Company if she is not serving as the Chief Executive Officer of the Company pursuant to the terms and conditions of the Employment Agreement as of the fourth anniversary of the employment agreement (October, 2022); The following table summarizes the warrant activities during the six months ended February 28, 2019 and the year ended August 31, 2018, respectively: Number of Warrants Weighted- Average Price Per Share Outstanding at August 31, 2018 2,830,000 $ 0.79 Granted 20,660,000 0.02 Canceled or expired - - Exercised (20,000,000 ) 0.00 Outstanding at February 28, 2019 3,490,000 $ 0.74 Exercisable at February 28, 2019 2,810,000 $ 0.79 Intrinsic value at February 28, 2019 and August 31, 2018 $ - $ - The fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions: Grant Date For the six months ended February 28, 2019 Risk-free interest rate at grant date 1.11% -2.92% Expected stock price volatility 159% - 251% Expected dividend payout - Expected option in life-years .7 - 6.0 years OPTIONS On July 26, 2017 the Company granted a nonemployee options to purchase 2,200,000 shares of common stock. The options have a three year term. 1,000,000 options were immediately exercisable on the date of issuance with an exercise price of $0.001 and the remaining 1,200,000 options vest over a period of three years at an exercise price of $1.00. On July 26, 2017, 1,000,000 shares were exercised. During the three and six months ended February 28, 2019 the Company recognized a gain of $(7,419) and $(376,250), respectively. Number of Weighted- Outstanding at August 31, 2018 1,200,000 $ 1.00 Granted - - Canceled or expired - - Exercised - - Outstanding at February 28, 2019 1,200,000 $ 1.00 Exercisable at February 28, 2019 900,000 1.00 Intrinsic value at February 28, 2019 and August 31, 2018 $ - $ -

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Feb. 28, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	6. COMMITMENTS AND CONTINGENCIES On January 22, 2018, the Company entered into a sales representation agreement to manage and solicit orders in a set territory, the United States, with an initial term of six months. The sales representative shall be compensated 6% of the net sales and three year warrants monthly to purchase 10,000 shares of common stock at an exercise price of $0.50. Warrants may be exercised after six month anniversary of issuance date. On February 1, 2018 the Company entered into a consulting agreement with Optimal Setup LLC for a term of one year to advise the Company on search engine optimization and digital marketing. Optimal Setup LLC shall receive monthly for services performed $2,500 and 10,000 warrants for common stock exercisable for cash price of $0.40. Warrants may be exercised after six month anniversary date. The warrants were granted on February 22, 2018. On March 2, 2018 the Company entered into a two year management agreement with Global Corporate Management, LLC (“GCM”). Pursuant to this agreement, the Company agreed to pay $4,000 and to issue 150,000 common stock purchase warrants (exercise price of $0.50, 5 year term, exercisable 6 months after issuance). The Company shall pay to GCM a commission equal to 10% of all sales every month. The commission will be paid only for the sales which have closed and cash has been paid to the Company. As of February 28, 2019 GCM has not earned any commissions. On March 20, 2018 the Company entered into a consulting agreement with Patagonia Global Trading, LLC. Upon execution of this agreement and upon the consultant signing their first customer, acceptable by the Company, and for services rendered, the Company agreed to issue 50,000 common stock purchase warrants to purchase common stock at an exercise price of $0.30 per share. As of November 30, 2018 Patagonia Global Trading, LLC, had not signed any customers and had not earned any warrants. The Company agreed to pay a total commission rate of 10% of the gross sale amount to be paid in the form of cash or warrants to purchase shares of common stock of the Company at a purchase price of $0.30 per share, exercisable 6 months after issuance. The commission will be paid on net sales from protected accounts and the consultant will be issued warrants on net invoices that are paid in full and money is received. On April 16, 2018 the Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000 warrants to purchase common stock with an exercise price of $0.60. However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in “cashless exercise”. Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. In May 2018 the Company entered into an agreement with Seidman Food Brokerage Inc., pursuant to which the Company appointed Seidman Food Brokerage, Inc. as its non-exclusive regional sales and marketing representative for the company’s product line for 12 months. The broker will be paid a monthly commission equal to the greater of (1) 5% of collected sales for all invoices generated for CBD products available from their product line for human consumption for a particular month or (2) solely with respect to the first six months of the term of the agreement. As of February 28, 2019 Seidman Food Brokerage, Inc. has not earned any commissions. Pursuant to a securities purchase agreement dated March 5, 2018, in the event that, in the six month period commencing on the closing date of such purchase agreement, the Company were to sell common stock at a price lower than $0.10 per share (or common stock equivalents with a conversion or exercise price lower than $0.10 per share (each as adjusted for stock splits, stock dividends, and similar transactions, the “Subsequent Financing Price”), the Company was required to promptly issue additional shares of common stock to the purchaser for no additional consideration, such that the total number of shares of common stock received by the purchaser under the Agreement would be equal to the total purchase price of $300,000 divided by such lower subsequent financing price. The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer or employee of the Company for a period of 12 months from the closing date. Pursuant to a securities purchase agreement dated March 21, 2018, in the event that, in the six month period commencing on the closing date of such purchase agreement, the Company were to sell common stock at a price lower than $0.10 per share (or common stock equivalents with a conversion or exercise price lower than $0.10 per share (each as adjusted for stock splits, stock dividends, and similar transactions), the Company was required to promptly issue additional shares of common stock to the purchaser for no additional consideration, such that the total number of shares of common stock received by the purchaser under the Agreement would be equal to the total purchase price of $50,000 divided by such lower subsequent financing price. The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer or employee of the Company for a period of 12 months from the closing date. Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer, or employee of the Company for a period of 12 months from the closing date. As of February 28, 2019 the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet.

Subsequent Events

Subsequent Events	6 Months Ended
	Feb. 28, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	7. SUBSEQUENT EVENTS On March 20, 2019 the Company issued 500,000 shares of common stock pursuant to a consulting agreement. The term of the agreement is one year and the Company agreed to pay the consultant $20,000 per month once it receives proceeds of financing transactions of at least $250,000. Between April 1, 2019 to April 12, 2019, the Company sold a total of 5,300,000 shares of common stock for proceeds of $110,500. On April 22, 2019, the Company entered into an exchange agreement with McGlothlin Holdings, Ltd. (“McGlothlin”). Pursuant to the exchange agreement, McGlothlin exchanged convertible debentures of the Company, in the original principal amounts of $540,000 and $120,000, respectively, and 1,000,000 warrants to purchase shares of common stock of the Company, for an aggregate of 11,000,000 newly issued shares of common stock of the Company. On April 22, 2019, the Company entered into an exchange agreement with Alneil Associates (“Alneil”). Pursuant to the exchange agreement, Alneil exchanged a convertible debenture of the Company, in the original principal amount of $180,000, and 300,000 warrants to purchase shares of common stock of the Company, for an aggregate of 3,000,000 newly issued shares of common stock of the Company.

Nature of Operations, Signifi_2

Nature of Operations, Significant Accounting Policies and Going Concern (Policies)	6 Months Ended
	Feb. 28, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Bespoke Extracts, Inc, a Nevada corporation (the “Company”), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company’s annual report on Form 10-K for the fiscal year ended August 31, 2018 filed with the Securities and Exchange Commission (the “SEC”) on December 14, 2018. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of February 28, 2019, and the results of operations and cash flows for the three and six months ended February 28, 2019 and 2018. The results of operations for the six months ended February 28, 2019 are not necessarily indicative of the results that may be expected for the entire fiscal year. Certain prior period amounts have been reclassified to conform to current period presentation.
Going Concern	Going Concern The accompanying unaudited consolidated financial statements have been prepared assuming a continuation of the Company as a going concern. The Company has a working capital deficit as of February 28, 2019 and negative cash flows from operations for the six months ended February 28, 2019. These conditions raise substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty.
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and market being determined as the lower of replacement cost or net realizable value. The Company records inventory write-downs for estimated obsolescence of unmarketable inventory based upon assumptions about future demand and market conditions. As of February 28, 2019 and August 31, 2018, inventory amounted to $54,184 and $61,857, respectively, which consisted of finished goods.
Revenue Recognition	Revenue Recognition The Company recognizes revenue from product sales to customers, distributors and resellers when products that do not require further services or installation by the Company are shipped, when there are no uncertainties surrounding customer acceptance and when collectability is reasonably assured. Cash received by the Company prior to shipment is recorded as deferred revenue. Sales are made to customers under terms allowing certain limited rights of return and other limited product and performance warranties for which provision has been made in the accompanying unaudited consolidated financial statements. Amounts billed to customers in sales transactions related to shipping and handling, represent revenues earned for the goods provided and are included in net sales. Costs of shipping and handling are included in cost of products sold. The Company accounts for revenue in accordance with Topic 606 which was adopted at the beginning of fiscal year 2018 using the modified retrospective method. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company did not recognize any cumulative-effect adjustment to retained earnings upon adoption as the effect was immaterial.
Net Income / Loss per Share	Net Income / Loss per Share Basic income / loss per share amounts are computed based on net income / loss divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the “if converted” method. Outstanding options, warrants and convertible debt were excluded from the calculation of diluted income / loss per share during 2018 and 2017 because their inclusion would have been anti-dilutive.

Note Payable - Related Party (T

Note Payable - Related Party (Tables)	6 Months Ended
	Feb. 28, 2019
Debt Disclosure [Abstract]
Schedule of notes payable to related party	February 28, August 31, Notes payable – related party at beginning of period $ 50 $ 50 Payments on notes payable – related party - - Borrowings on notes payable – related party - - Note payable – related party at end of period $ 50 $ 50 February 28, August 31, 2018 Notes payable – related party at beginning of period $ - $ 153,000 Payments on notes payable – related party - (30,000 ) Conversion - (80,000 ) Exchange for purchase of Company assets - (43,000 ) Note payables – related party at end of period $ - $ -

Convertible Debenture - Relat_2

Convertible Debenture - Related Party (Tables)	6 Months Ended
	Feb. 28, 2019
Convertible Debenture Related Party [Abstract]
Schedule of convertible debenture net of unamortized discount	February 28, August 31, Related Party Convertible debenture $ 540,000 $ 540,000 Unamortized discount (41,232 ) (184,364 ) Related Party Convertible debenture, net of unamortized discount $ 498,768 $ 355,636 February 28, August 31, Related Party Convertible debenture $ 180,000 $ 180,000 Unamortized discount (66,753 ) (98,847 ) Related Party Convertible debenture, net of unamortized discount $ 113,247 $ 81,153 February 28, August 31, Related Party Convertible debenture $ 120,000 $ 120,000 Unamortized discount - (14,936 ) Related Party Convertible debenture, net of unamortized discount $ 120,000 $ 105,064

Equity (Tables)

Equity (Tables)	6 Months Ended
	Feb. 28, 2019
Equity [Abstract]
Schedule of warrant activity and stock options	Number of Warrants Weighted- Average Price Per Share Outstanding at August 31, 2018 2,830,000 $ 0.79 Granted 20,660,000 0.02 Canceled or expired - - Exercised (20,000,000 ) 0.00 Outstanding at February 28, 2019 3,490,000 $ 0.74 Exercisable at February 28, 2019 2,810,000 $ 0.79 Intrinsic value at February 28, 2019 and August 31, 2018 $ - $ - Number of Weighted- Outstanding at August 31, 2018 1,200,000 $ 1.00 Granted - - Canceled or expired - - Exercised - - Outstanding at February 28, 2019 1,200,000 $ 1.00 Exercisable at February 28, 2019 900,000 1.00 Intrinsic value at February 28, 2019 and August 31, 2018 $ - $ -
Schedule of fair value of the warrants was estimated using the Black-Scholes option pricing model	Grant Date For the six months ended February 28, 2019 Risk-free interest rate at grant date 1.11% -2.92% Expected stock price volatility 159% - 251% Expected dividend payout - Expected option in life-years .7 - 6.0 years

Nature of Operations, Signifi_3

Nature of Operations, Significant Accounting Policies and Going Concern (Details) - USD ($)	Feb. 28, 2019	Aug. 31, 2018
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Inventory finished goods	$ 54,184	$ 61,857

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2019	Feb. 28, 2018	Feb. 28, 2019	Feb. 28, 2018	Feb. 21, 2017
Asset Purchase Agreement (Textual)
Total approximate amount include in asset purchase agreement					$ 20,185
Number of common stock					200,000
Common stock value					$ 30,000
Amortization expense	$ 837	$ 796	$ 1,673	$ 1,632
Amortized over period			15 years

Note Payable - Related Party (D

Note Payable - Related Party (Details) - 7% unsecured promissory note [Member] - USD ($)	6 Months Ended	12 Months Ended
	Feb. 28, 2019	Aug. 31, 2018
Debt Instrument [Line Items]
Notes payable - related party at beginning of period	$ 50	$ 50
Payments on notes payable - related party
Borrowings on notes payable - related party
Note payable - related party at end of period	$ 50	$ 50

Note Payable - Related Party _2

Note Payable - Related Party (Details 1) - Notes payable related parties [Member] - USD ($)	6 Months Ended	12 Months Ended
	Feb. 28, 2019	Aug. 31, 2018
Debt Instrument [Line Items]
Notes payable - related party at beginning of period		$ 153,000
Payments on notes payable - related party		(30,000)
Conversion		(80,000)
Exchange for purchase of Company assets		(43,000)
Note payables - related party at end of period

Note Payable - Related Party _3

Note Payable - Related Party (Details Textual) - USD ($)

Nov. 17, 2016

Nov. 14, 2016

Aug. 15, 2016

Jul. 05, 2016

May 31, 2018

Apr. 17, 2017

Mar. 31, 2017

Feb. 14, 2017

Oct. 27, 2016

May 17, 2016

Apr. 27, 2016

Feb. 28, 2019

Feb. 28, 2018

Aug. 31, 2018

Note Payable - Related Party (Textual)

Amortization of debt discount

$ 190,162

$ 200,521

7% unsecured promissory note [Member]

Note Payable - Related Party (Textual)

Unsecured promissory note issued

$ 16,000

Unsecured promissory note maturity, description

Maturity of six months from the date of issuance.

7% unsecured promissory note [Member] | Shareholder [Member]

Note Payable - Related Party (Textual)

Unsecured promissory note issued

$ 80,000

$ 7,000

$ 10,000

$ 10,000

Unsecured promissory note maturity, description

Maturity date of six months from the date of issuance.

Mature on April 18, 2018

Maturity date of six months from the date of issuance.

Maturity date of six months from the date of issuance.

Maturity date of six months from the date of issuance.

Debt instrument, description

The Company issued a total of 10,050,000 shares of common stock to convert $80,000 principal and $400 of accrued interest into common stock and the remaining $43,000 was exchanged with an additional $2,000 of accrued interest to purchase assets of the Company.

Conversion price

$ 0.008

Beneficial conversion feature

$ 123,000

Amortization of debt discount

$ 123,000

7% unsecured promissory note [Member] | Chief Executive Officer [Member]

Note Payable - Related Party (Textual)

Unsecured promissory note issued

$ 3,000

$ 2,500

Repaid of principal amount

$ 5,500

Unsecured promissory note maturity, description

Matured six months from date of issuance.

Matured six months from the date of issuance.

7% unsecured promissory note [Member] | Lyle Hauser [Member]

Note Payable - Related Party (Textual)

Unsecured promissory note issued

$ 30,000

Repaid of principal amount

$ 30,000

Unsecured promissory note maturity, description

Matured six months from the date of issuance.

Accrued interest

$ 2,811

Convertible Debenture - Relat_3

Convertible Debenture - Related Party (Details) - USD ($)	Feb. 28, 2019	Aug. 31, 2018
Convertible Debenture [Member]
Marketable Securities [Line Items]
Related Party Convertible debenture	$ 540,000	$ 540,000
Unamortized discount	(41,232)	(184,364)
Related Party Convertible debenture, net of unamortized discount	498,768	355,636
Convertible Debenture One [Member]
Marketable Securities [Line Items]
Related Party Convertible debenture	180,000	180,000
Unamortized discount	(66,753)	(98,847)
Related Party Convertible debenture, net of unamortized discount	113,247	81,153
Convertible Debenture Two [Member]
Marketable Securities [Line Items]
Related Party Convertible debenture	120,000	120,000
Unamortized discount		(14,936)
Related Party Convertible debenture, net of unamortized discount	$ 120,000	$ 105,064

Convertible Debenture - Relat_4

Convertible Debenture - Related Party (Details Textual) - USD ($)	Dec. 13, 2017	Apr. 11, 2017	Aug. 28, 2017	Feb. 28, 2019	Feb. 28, 2019	Feb. 28, 2018	Aug. 31, 2018
Convertible Debenture - Related Party (Textual)
Fair value of related party						$ 51,503
Convertible Debt Securities [Member]
Convertible Debenture - Related Party (Textual)
Maturity terms		2 years
Convertible debenture amount		$ 540,000
Original issue discount of convertible debt		$ 180,000
Interest rate		0.00%
Aggregate of shares of common stock		2,700,000
Common stock purchase warrants		900,000
Convertible debenture, description		The conversion price of the outstanding balance is the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the note the lender was entitled to receive greater of 5% every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principal.
Accured interest					48,265		$ 34,015
Amortization				$ 99,776	143,132
Fair value of warrants		$ 44,981
Fair value of related party		157,509
Aggregating discount to note		$ 202,490
Convertible Debenture One [Member]
Convertible Debenture - Related Party (Textual)
Maturity terms	1 year
Convertible debenture amount				180,000	180,000		180,000
Executed convertible debenture	$ 120,000
Original issue discount of convertible debt	$ 20,000
Interest rate	0.00%
Aggregate of shares of common stock	200,000
Common stock purchase warrants	100,000
Convertible debenture, description	The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the debenture the lender was entitled to receive the greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principal.
Accured interest					34,250		20,000
Amortization				8,320	14,936
Fair value of warrants	$ 32,930
Related Party [Member]
Convertible Debenture - Related Party (Textual)
Maturity terms			2 years
Convertible debenture amount			$ 180,000
Original issue discount of convertible debt			$ 60,000
Interest rate			0.00%
Aggregate of shares of common stock			900,000
Common stock purchase warrants			300,000
Convertible debenture, description			The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the debenture the lender was entitled to receive the greater of 5% of every dollar raised through financing or every dollar of revenue generated through the earlier of the maturity date or repayment of the principal.
Accured interest					39,250		$ 25,000
Amortization				$ 16,032	$ 32,094
Fair value of warrants			$ 68,499

Equity (Details)

Equity (Details)	6 Months Ended
	Feb. 28, 2019USD ($)$ / sharesshares
Options [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance | shares	1,200,000
Number of Warrants/Options, Granted | shares
Number of Warrants/Options, Canceled or expired | shares
Number of Warrants/Options, Exercised | shares
Number of Warrants/Options, Outstanding Ending balance | shares	1,200,000
Number of Warrants/Options, Exercisable | shares	900,000
Number of Warrants/Options, Intrinsic value | $
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares	$ 1
Weighted-Average Price Per Share, Granted | $ / shares
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Exercised | $ / shares
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares	1
Weighted-Average Price Per Share, Exercisable | $ / shares	$ 1
Warrants [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance | shares	2,830,000
Number of Warrants/Options, Granted | shares	20,660,000
Number of Warrants/Options, Canceled or expired | shares
Number of Warrants/Options, Exercised | shares	(20,000,000)
Number of Warrants/Options, Outstanding Ending balance | shares	3,490,000
Number of Warrants/Options, Exercisable | shares	2,810,000
Number of Warrants/Options, Intrinsic value | $
Weighted-Average Price Per Share, Outstanding Beginning balance | $ / shares	$ 0.79
Weighted-Average Price Per Share, Granted | $ / shares	0.02
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Exercised | $ / shares	0
Weighted-Average Price Per Share, Outstanding Ending balance | $ / shares	0.74
Weighted-Average Price Per Share, Exercisable | $ / shares	$ 0.79

Equity (Details 1)

Equity (Details 1)	6 Months Ended
	Feb. 28, 2019
Class of Warrant or Right [Line Items]
Expected dividend payout
Minimum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.11%
Expected stock price volatility	159.00%
Expected option in life-years	8 months 12 days
Maximum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	2.92%
Expected stock price volatility	251.00%
Expected option in life-years	6 years

Equity (Details Textual)

Equity (Details Textual) - USD ($)	Nov. 06, 2018	Oct. 13, 2018	Aug. 01, 2018	Mar. 02, 2018	Oct. 31, 2018	Apr. 16, 2018	Feb. 22, 2018	Jan. 22, 2018	Jul. 26, 2017	May 22, 2017	Feb. 28, 2019	Nov. 30, 2018	Feb. 28, 2018	Nov. 30, 2017	Feb. 28, 2019	Feb. 28, 2018	Aug. 31, 2018	Aug. 31, 2017	Oct. 30, 2018	May 31, 2017
Equity (Textual)
Common stock, shares authorized											800,000,000				800,000,000		800,000,000
Common stock, par value											$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares authorized											50,000,000				50,000,000		50,000,000
Preferred stock, par value											$ 0.001				$ 0.001		$ 0.001
Fair value of amortized discount											$ 837		$ 796		$ 1,673	$ 1,632
Option expense															(1,629,580)	579,419
Proceeds from exercise of warrants															2,000
Unamortized expense											2,381,627				2,381,627
Proceeds of sale amount											165,000	$ 120,000		$ 60,300
Common stock issued value													12,400	$ 51,503
Fair value award determined value															2,598,138
Fair value award determined value recognized											$ 162,384				$ 216,512
Employee share based award and the forfeiture										$ 2,440,768
Employee share based award and the forfeiture cash paid										$ 1,600
Sponsorship [Member]
Equity (Textual)
Common stock issued value		$ 120,000
Common stock shares issued		1,000,000
Mr. Yahr [Member]
Equity (Textual)
Common stock issued value	$ 1,600
Warrant [Member]
Equity (Textual)
Issuance of options															20,660,000
Options Exercised															(20,000,000)
Convertible debt, description															Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company. As of February 28, 2019, $0 remains to be expensed over the remaining vesting period.
Common Stock [Member]
Equity (Textual)
Options Exercised															20,000,000
Shares of common stock forfeited	16,000,000											(16,000,000)						(20,000,000)
Sale of shares common stock											6,966,667	2,000,000		900,000
Proceeds of sale amount											$ 6,967	$ 2,000		$ 900
Common stock issued value													$ 1,550	$ 900
Common stock shares issued													1,550,000	900,000
Employee Stock Option [Member]
Equity (Textual)
Issuance of options									2,200,000
Options Exercised									1,000,000
Compensation (gain) / expense recognized											(7,419)				$ (376,250)
Terms of options									3 years
Options exercise price									$ 0.001
Options vested shares									1,200,000
Options vested shares, exercise price									$ 1
Dr. Hellman [Member]
Equity (Textual)
Warrant to purchase of common stock			60,000
Common stock per share price			$ 0.60
Terms of warrants			1 year
Compensation (gain) / expense recognized											8,225				(107,618)
President [Member]
Equity (Textual)
Warrant to purchase of common stock										20,000,000
Common stock per share price										$ 0.0001
Fair value of warrants																	$ 10,998,105
Terms of warrants										3 years
Compensation expense recognized over service period																	3 years
Chief Executive Officer [Member] | Warrant [Member]
Equity (Textual)
Warrant to purchase of common stock					20,000,000														20,000,000
Common stock per share price																			$ 0.0001
Shares of common stock forfeited										20,000,000
Annual salary																			$ 96,000
Chief Executive Officer [Member] | Common Stock [Member]
Equity (Textual)
Warrant to purchase of common stock					20,000,000														20,000,000
Common stock per share price																			$ 0.0001
Proceeds from exercise of warrants					$ 2,000
Annual salary																			$ 96,000
Mr. Yahr [Member]
Equity (Textual)
Aggregate of shares																				20,000,000
Global Corporate Management, LLC [Member]
Equity (Textual)
Warrant to purchase of common stock				150,000
Common stock per share price				$ 0.50
Terms of warrants				5 years
Compensation (gain) / expense recognized											(8,363)				$ (273,049)
Aggregate common stock shares issued				4,000
Aggregate of shares				3,600,000
Securities Purchase Agreement [Member]
Equity (Textual)
Aggregate common stock shares issued															500,000
Aggregate common stock value															$ 76,000
Description of common stock sales															Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price.
Common stock issued value															$ 76,000
Common stock shares issued															500,000
Consulting Agreement [Member]
Equity (Textual)
Warrant to purchase of common stock							10,000
Common stock per share price							$ 0.40
Terms of warrants							3 years
Compensation (gain) / expense recognized											(197)				$ (32,061)
Aggregate of shares							120,000
Consulting Agreement [Member] | Dr. David Hellman [Member]
Equity (Textual)
Warrant to purchase of common stock						50,000
Common stock per share price						$ 0.60
Terms of warrants						1 year
Aggregate of shares						720,000
Consulting agreement, description						If the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exercised on a cashless basis. Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales.
Sales Representation Agreement [Member]
Equity (Textual)
Warrant to purchase of common stock								10,000
Common stock per share price								$ 0.50
Terms of warrants								3 years
Compensation (gain) / expense recognized											$ 321				$ (57,382)
Aggregate of shares								60,000
Between September 1, 2018 and February 28, 2019 [Member]
Equity (Textual)
Sale of shares common stock											8,966,667
Proceeds of sale amount											$ 285,000

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)

Aug. 01, 2018

Jun. 06, 2018

Mar. 21, 2018

Mar. 05, 2018

Mar. 02, 2018

Feb. 01, 2018

Apr. 16, 2018

Feb. 22, 2018

Jan. 22, 2018

Feb. 28, 2019

Feb. 28, 2018

Feb. 28, 2019

Feb. 28, 2018

Mar. 20, 2018

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Monthly service received

$ 4,280

$ 15,888

Global Corporate Management, LLC [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.50

Warrant to purchase of common stock

150,000

Terms of warrants

5 years

Payments to issue of common stock

$ 4,000

Common stock shares issued

4,000

Patagonia Global Trading, Llc [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.30

Warrant to purchase of common stock

50,000

Securities Purchase Agreement [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Exercise price

$ 0.10

$ 0.10

$ 0.10

Dividend

$ 50,000

$ 50,000

$ 300,000

Common stock valued

$ 76,000

Common stock shares issued

500,000

Cash compensation, description

The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer, or employee of the Company for a period of 12 months from the closing date.

The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer or employee of the Company for a period of 12 months from the closing date.

The Company also agreed that it would not pay total cash compensation of more than $100,000 to any director, officer or employee of the Company for a period of 12 months from the closing date.

Consulting Agreement [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.40

Warrant to purchase of common stock

10,000

Terms of warrants

3 years

Consulting Agreement [Member] | Dr David Hellman [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.60

$ 0.60

Warrant to purchase of common stock

60,000

50,000

Terms of warrants

1 year

1 year

Consulting agreement, description

However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $0.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in "cashless exercise". Additionally, the Company agreed to pay to the consultant 10% of retail sales and 5% of wholesale sales.

Consulting Agreement [Member] | Optimal Setup Llc [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.40

Warrant to purchase of common stock

10,000

Terms of warrants

1 year

Monthly service received

$ 2,500

Consulting Agreement [Member] | Patagonia Global Trading, Llc [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.30

Warrant to purchase of common stock

50,000

Consulting agreement, description

The Company agreed to pay a total commission rate of 10% of the gross sale amount to be paid in the form of cash or warrants to purchase shares of common stock of the Company

Sales Representation Agreement [Member]

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Common stock per share price

$ 0.50

Warrant to purchase of common stock

10,000

Percentage of net sales

6.00%

Terms of warrants

3 years

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Apr. 12, 2019	Apr. 22, 2019	Mar. 20, 2019	Feb. 28, 2019	Nov. 30, 2018	Nov. 30, 2017
Subsequent Events (Textual)
Proceeds from sale of common stock, value				$ 165,000	$ 120,000	$ 60,300
Subsequent Event [Member]
Subsequent Events (Textual)
Proceeds from sale of common stock, value	$ 110,500
Issued shares of common stock	5,300,000
Subsequent Event [Member] | McGlothlin Holdings, Ltd. [Member]
Subsequent Events (Textual)
Issued shares of common stock		11,000,000
Pursuant to exchange agreement		$ 540,000
Convertible debentures original principal amount		$ 120,000
Warrants to purchase of common stock shares		1,000,000
Subsequent Event [Member] | Alneil Associates [Member]
Subsequent Events (Textual)
Issued shares of common stock		3,000,000
Pursuant to exchange agreement		$ 180,000
Warrants to purchase of common stock shares		300,000
Subsequent Event [Member] | Consulting Agreement [Member]
Subsequent Events (Textual)
Issued shares of common stock			500,000
Consulting agreement term			1 year
Consulting agreement, description			The Company agreed to pay the consultant $20,000 per month once it receives proceeds of financing transactions of at least $250,000.